I'd honestly say that they didn't rely *enough* on established results—like those coming out of countries with SARS experience—and also on many other questions: seasonality, immunity, etc. Instead of disruptive I'd say we needed more trade-off discussions.
-
This Tweet is unavailable.
-
-
Yes it's about appreciating that there are different ways to make predictions in science on a new agent. Some are by inference from a related agent. Some are by direct experimentation with the new agent. Some are by empirical data gathering. All are important in the trade-off.
1 reply 0 retweets 1 like
Indeed. It's especially hard when there is a individual/population level trade-off because clinical thinking is, naturally, oriented towards the person in front of the clinician whereas pandemics and shortage have population implications that few like to ponder too much.
2:43 PM - 2 Feb 2021
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.